摘要
Abstract
Objective To compare clinical efficacy and safety of azithromycin sequential therapy with erythromycin mycoplasma pneumonia (MP) in drug use. Methods In our hospital from November 2010 to November 2012 were treated 36 cases of patients with MP random number table is divided into the treatment group and the control group, two groups of children were given after admission fever, asthma,cough and phlegm and other conventional symptomatic treatment.Control group on the basis of conventional therapy with erythromycin, azithromycin sequential therapy treatment group. Results The treatment group and the control group the total effective rate was 94.4%, 83.3%, the difference was statistically significant (P<0.05);treatment group of children with fever, pulmonary rales, duration and average hospital stay was (3.20 ± 1.74) d,(5.71 ± 2.13) d, (8.28 ± 1.64) d, were significantly shorter than the control group (P < 0.05); treatment group, the incidence of adverse drug reactions was significantly lower than the control group (P < 0.05). Conclusion azithromycin sequential therapy in the treatment of pediatric MP than erythromycin better, more secure.关键词
阿奇霉素/红霉素/序贯疗法/小儿支原体肺炎Key words
Azithromycin/Erythromycin/Sequential therapy/Mycoplasma pneumonia分类
医药卫生
